Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 194 citing articles:

Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids
Shyam H. Kamble, Abhisheak Sharma, Tamara I. King, et al.
Toxicology Letters (2019) Vol. 319, pp. 148-154
Open Access | Times Cited: 61
Mitragyna speciosa: Clinical, Toxicological Aspects and Analysis in Biological and Non-Biological Samples
Vânia Meireles, Tiago Rosado, Mário Barroso, et al.
Medicines (2019) Vol. 6, Iss. 1, pp. 35-35
Open Access | Times Cited: 60
Evaluating kratom alkaloids using PHASE
Christopher R. Ellis, Rebecca Racz, Naomi L. Kruhlak, et al.
PLoS ONE (2020) Vol. 15, Iss. 3, pp. e0229646-e0229646
Open Access | Times Cited: 53
Prevalence and characteristics of self-reported kratom use in a representative US general population sample
Jordan R. Covvey, Samantha M. Vogel, Alyssa M. Peckham, et al.
Journal of Addictive Diseases (2020) Vol. 38, Iss. 4, pp. 506-513
Closed Access | Times Cited: 50
Seasonal and Geographic Variation in Alkaloid Content of Kratom (Mitragyna speciosa (Korth.) Havil.) from Thailand
Narumon Sengnon, Phanita Vonghirundecha, Wiraphon Chaichan, et al.
Plants (2023) Vol. 12, Iss. 4, pp. 949-949
Open Access | Times Cited: 20
Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Current Addiction Reports (2023) Vol. 10, Iss. 2, pp. 317-334
Open Access | Times Cited: 17
Evaluating the hematological and clinical-chemistry parameters of kratom (Mitragyna speciosa) users in Malaysia
Darshan Singh, Christian P. Müller, Vikneswaran Murugaiyah, et al.
Journal of Ethnopharmacology (2017) Vol. 214, pp. 197-206
Closed Access | Times Cited: 59
Motives for using Kratom (Mitragyna speciosa Korth.) among regular users in Malaysia
Darshan Singh, Suresh Narayanan, Christian P. Müller, et al.
Journal of Ethnopharmacology (2018) Vol. 233, pp. 34-40
Closed Access | Times Cited: 54
Update on the Pharmacology and Legal Status of Kratom
Walter C. Prozialeck
Journal of Osteopathic Medicine (2016) Vol. 116, Iss. 12, pp. 802-809
Open Access | Times Cited: 53
Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
Zurina Hassan, Oliver G. Bosch, Darshan Singh, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 52
Self-reported prevalence and severity of opioid and kratom (Mitragyna speciosa korth.) side effects
Azlin Saref, Sharifah Suraya, Darshan Singh, et al.
Journal of Ethnopharmacology (2019) Vol. 238, pp. 111876-111876
Closed Access | Times Cited: 51
Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
Silvia Graziano, Laura Orsolini, Maria Concetta Rotolo, et al.
Current Neuropharmacology (2016) Vol. 15, Iss. 5
Open Access | Times Cited: 50
Nigritanine as a New Potential Antimicrobial Alkaloid for the Treatment of Staphylococcus aureus-Induced Infections
Bruno Casciaro, Andrea Calcaterra, Floriana Cappiello, et al.
Toxins (2019) Vol. 11, Iss. 9, pp. 511-511
Open Access | Times Cited: 47
Evaluation of the Mitragynine Content, Levels of Toxic Metals and the Presence of Microbes in Kratom Products Purchased in the Western Suburbs of Chicago
Walter C. Prozialeck, Joshua R. Edwards, Peter C. Lamar, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5512-5512
Open Access | Times Cited: 40
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
Shyam H. Kamble, Erin C. Berthold, Tamara I. King, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1104-1112
Open Access | Times Cited: 36
Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally?
Pierluigi Simonato, Francesco Saverio Bersani, Rita Santacroce, et al.
Human Psychopharmacology Clinical and Experimental (2017) Vol. 32, Iss. 3, pp. e2580-e2580
Open Access | Times Cited: 46
Treatment of Kratom Dependence With Buprenorphine-Naloxone Maintenance
Megan Buresh
Journal of Addiction Medicine (2018) Vol. 12, Iss. 6, pp. 481-483
Closed Access | Times Cited: 43
The Scheduling of Kratom and Selective Use of Data
O. Hayden Griffin, Megan Webb
Journal of Psychoactive Drugs (2017) Vol. 50, Iss. 2, pp. 114-120
Closed Access | Times Cited: 42
Treatment of Kratom Withdrawal and Addiction With Buprenorphine
Azin Khazaeli, Jason M. Jerry, Mohsen Vazirian
Journal of Addiction Medicine (2018) Vol. 12, Iss. 6, pp. 493-495
Closed Access | Times Cited: 40
Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic
Caroline Stokes Osborne, Amanda N. Overstreet, Don C. Rockey, et al.
Journal of Investigative Medicine High Impact Case Reports (2019) Vol. 7
Open Access | Times Cited: 38
Substance-induced Psychosis in Youth
David Beckmann, Kelsey L. Lowman, Jessica E. Nargiso, et al.
Child and Adolescent Psychiatric Clinics of North America (2019) Vol. 29, Iss. 1, pp. 131-143
Open Access | Times Cited: 37
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Attitudes towards Kratom use, decriminalization and the development of a community-based Kratom control mechanism in Southern Thailand
Sayamol Charoenratana, Cholnapa Anukul, Apinun Aramrattana
International Journal of Drug Policy (2021) Vol. 95, pp. 103197-103197
Open Access | Times Cited: 28
Psychoactive Substances of Natural Origin: Toxicological Aspects, Therapeutic Properties and Analysis in Biological Samples
Joana Gonçalves, Ângelo Luís, Eugénia Gallardo, et al.
Molecules (2021) Vol. 26, Iss. 5, pp. 1397-1397
Open Access | Times Cited: 27
Kratom: History, pharmacology, current user trends, adverse health effects and potential benefits
Oliver Grundmann, Robert G. Hendrickson, Michael I. Greenberg
Disease-a-Month (2022) Vol. 69, Iss. 6, pp. 101442-101442
Closed Access | Times Cited: 20

Scroll to top